<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35401523</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers.</ArticleTitle><Pagination><StartPage>848886</StartPage><MedlinePgn>848886</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">848886</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.848886</ELocationID><Abstract><AbstractText>Long-COVID is a new emerging syndrome worldwide that is characterized by the persistence of unresolved signs and symptoms of COVID-19 more than 4 weeks after the infection and even after more than 12 weeks. The underlying mechanisms for Long-COVID are still undefined, but a sustained inflammatory response caused by the persistence of SARS-CoV-2 in organ and tissue sanctuaries or resemblance with an autoimmune disease are within the most considered hypotheses. In this study, we analyzed the usefulness of several demographic, clinical, and immunological parameters as diagnostic biomarkers of Long-COVID in one cohort of Spanish individuals who presented signs and symptoms of this syndrome after 49 weeks post-infection, in comparison with individuals who recovered completely in the first 12 weeks after the infection. We determined that individuals with Long-COVID showed significantly increased levels of functional memory cells with high antiviral cytotoxic activity such as CD8<sup>+</sup> TEMRA cells, CD8<sup>&#xb1;</sup>TCR&#x3b3;&#x3b4;<sup>+</sup> cells, and NK cells with CD56<sup>+</sup>CD57<sup>+</sup>NKG2C<sup>+</sup> phenotype. The persistence of these long-lasting cytotoxic populations was supported by enhanced levels of CD4<sup>+</sup> Tregs and the expression of the exhaustion marker PD-1 on the surface of CD3<sup>+</sup> T lymphocytes. With the use of these immune parameters and significant clinical features such as lethargy, pleuritic chest pain, and dermatological injuries, as well as demographic factors such as female gender and O<sup>+</sup> blood type, a Random Forest algorithm predicted the assignment of the participants in the Long-COVID group with 100% accuracy. The definition of the most accurate diagnostic biomarkers could be helpful to detect the development of Long-COVID and to improve the clinical management of these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Gal&#xe1;n, Vig&#xf3;n, Fuertes, Murciano-Ant&#xf3;n, Casado-Fern&#xe1;ndez, Dom&#xed;nguez-Mateos, Mateos, Ramos-Mart&#xed;n, Planelles, Torres, Rodr&#xed;guez-Mora, L&#xf3;pez-Huertas and Coiras.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gal&#xe1;n</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vig&#xf3;n</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuertes</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Telecommunications Engineering, Universidad Polit&#xe9;cnica de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murciano-Ant&#xf3;n</LastName><ForeName>Mar&#xed;a Ar&#xe1;nzazu</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Family Medicine, Centro de Salud Doctor Pedro La&#xed;n Entralgo, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casado-Fern&#xe1;ndez</LastName><ForeName>Guiomar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dom&#xed;nguez-Mateos</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Family Medicine, Centro de Salud Doctor Pedro La&#xed;n Entralgo, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateos</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-Mart&#xed;n</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Planelles</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Microbiology and Immunology, University of Utah School of Medicine, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Mora</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Huertas</LastName><ForeName>Mar&#xed;a Rosa</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coiras</LastName><ForeName>Mayte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8+ T cells</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">NK cells</Keyword><Keyword MajorTopicYN="N">Random Forest algorithm</Keyword><Keyword MajorTopicYN="N">cytotoxic immune response</Keyword><Keyword MajorTopicYN="N">immune exhaustion</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>11</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35401523</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO . Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Kandeel M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, El-Beltagi HS. Omicron Variant Genome Evolution and Phylogenetics. J Med Virol (2021) 94(4):1627&#x2013;32. doi:&#xa0;10.1002/jmv.27515</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27515</ArticleId><ArticleId IdType="pmc">PMC9015349</ArticleId><ArticleId IdType="pubmed">34888894</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. . Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet (2020) 395:507&#x2013;13. doi:&#xa0;10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vig&#xf3;n L, Fuertes D, Garc&#xed;a-P&#xe9;rez J, Torres M, Rodr&#xed;guez-Mora S, Mateos E, et al. . Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity. Front Immunol (2021) 12:665329:665329. doi:&#xa0;10.3389/fimmu.2021.665329</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.665329</ArticleId><ArticleId IdType="pmc">PMC8187764</ArticleId><ArticleId IdType="pubmed">34122423</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M. Reid TR. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol (2021) 20:1&#x2013;9. doi:&#xa0;10.1007/s12016-021-08848-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients From Wuhan, China. Intensive Care Med (2020) 46:846&#x2013;8. doi:&#xa0;10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, et al. . Late Complications of COVID-19; a Systematic Review of Current Evidence. Arch Acad Emerg Med (2021) 9:e14. doi:&#xa0;10.22037/aaem.v9i1.1058</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v9i1.1058</ArticleId><ArticleId IdType="pmc">PMC7927752</ArticleId><ArticleId IdType="pubmed">33681819</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, B. Pearson CA, et al. . COVID-19 Length of Hospital Stay: A Systematic Review and Data Synthesis. BMC Med (2020) 18:270. doi:&#xa0;10.1186/s12916-020-01726-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01726-3</ArticleId><ArticleId IdType="pmc">PMC7467845</ArticleId><ArticleId IdType="pubmed">32878619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci Rep (2021) 11:16144. doi:&#xa0;10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K, Wen G, Wang J, Zhou S, Da W, Meng Y, et al. . Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era. Front Immunol (2021) 12:711741. doi:&#xa0;10.3389/fimmu.2021.711741</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.711741</ArticleId><ArticleId IdType="pmc">PMC8446426</ArticleId><ArticleId IdType="pubmed">34539642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and Predictors of Long COVID. Nat Med (2021) 27:626&#x2013;31. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>
Excellence NI for H and C. NICE . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 (2021). Available at: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of Post-Acute Covid-19 in Primary Care. BMJ (2020) 370:m3026. doi:&#xa0;10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: What do We Know About &#x201c;Long Covid&#x201d;? BMJ (2020) 370:m2815. doi:&#xa0;10.1136/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization RO for E . New Policy Brief Calls on Decision-Makers to Support Patients as 1 in 10 Report Symptoms of &#x201c;Long COVID.&#x201d; (2021). Available at: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2021/2/new-policy-brief-calls-on-decision-makers-to-support-patients-as-1-in-10-report-symptoms-of-long-covid.</Citation></Reference><Reference><Citation>Mitrani RD, Dabas N, Goldberger JJ. COVID-19 Cardiac Injury: Implications for Long-Term Surveillance and Outcomes in Survivors. Hear Rhythm (2020) 17:1984&#x2013;90. doi:&#xa0;10.1016/j.hrthm.2020.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.06.026</ArticleId><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. . Persistent Symptoms After Covid-19: Qualitative Study of 114 &#x201c;Long Covid&#x201d; Patients and Draft Quality Principles for Services. BMC Health Serv Res (2020) 20:1144. doi:&#xa0;10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long Covid in Adults Discharged From UK Hospitals After Covid-19: A Prospective, Multicentre Cohort Study Using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Heal Eur (2021) 8:100186. doi:&#xa0;10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID Risk - a Signal to Address Sex Hormones and Women&#x2019;s Health. Lancet Reg Heal - Eur (2021) 11:100242. doi:&#xa0;10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zhang Y, Moorman JP, Yao ZQ, Jia ZS. Viral (Hepatitis C Virus, Hepatitis B Virus, HIV) Persistence and Immune Homeostasis. Immunology (2014) 143:319&#x2013;30. doi:&#xa0;10.1111/imm.12349</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12349</ArticleId><ArticleId IdType="pmc">PMC4212946</ArticleId><ArticleId IdType="pubmed">24965611</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Y-H, Ni W, Wu Q, Li W-J, Li G-J, Wang W-D, et al. . Prolonged Viral Shedding in Feces of Pediatric Patients With Coronavirus Disease 2019. J Microbiol Immunol Infect (2020) 53:473&#x2013;80. doi:&#xa0;10.1016/j.jmii.2020.03.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.021</ArticleId><ArticleId IdType="pmc">PMC7141453</ArticleId><ArticleId IdType="pubmed">32276848</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D, Castro K, Schwarz S, Vaidy K, Rabinowitz S, Wallach T. Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection. JPGN Rep (2022) 3:e152. doi:&#xa0;10.1097/PG9.0000000000000152</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PG9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>To K, Tong JH, Chan PK, Au FW, Chim SS, Allen Chan K, et al. . Tissue and Cellular Tropism of the Coronavirus Associated With Severe Acute Respiratory Syndrome: An in-Situ Hybridization Study of Fatal Cases. J Pathol (2004) 202:157&#x2013;63. doi:&#xa0;10.1002/path.1510</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1510</ArticleId><ArticleId IdType="pmc">PMC7167900</ArticleId><ArticleId IdType="pubmed">14743497</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinale V, Capurso G, Ianiro G, Gasbarrini A, Arcidiacono PG, Alvaro D. Intestinal Permeability Changes With Bacterial Translocation as Key Events Modulating Systemic Host Immune Response to SARS-CoV-2: A Working Hypothesis. Dig Liver Dis (2020) 52:1383&#x2013;9. doi:&#xa0;10.1016/j.dld.2020.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7494274</ArticleId><ArticleId IdType="pubmed">33023827</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. . Inflammatory Responses and Inflammation-Associated Diseases in Organs. Oncotarget (2018) 9:7204&#x2013;18. doi:&#xa0;10.18632/oncotarget.23208</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.23208</ArticleId><ArticleId IdType="pmc">PMC5805548</ArticleId><ArticleId IdType="pubmed">29467962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse Functional Autoantibodies in Patients With COVID-19. Nature (2021) 595:283&#x2013;8. doi:&#xa0;10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. . Autoantibodies Against Type I IFNs in Patients With Life-Threatening COVID-19. Sci (80- ) (2020) 370:6515. doi:&#xa0;10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. A Negative COVID-19 Test Does Not Mean Recovery. Nature (2020) 584:170&#x2013;0. doi:&#xa0;10.1038/d41586-020-02335-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02335-z</ArticleId><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. . Detection of 2019 Novel Coronavirus (2019-Ncov) by Real-Time RT-PCR. Eurosurveillance (2020) 25:2000045. doi:&#xa0;10.2807/1560-7917.ES.2020.25.3.2000045</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO/2019-nCoV/laboratory/2020.6 . Emergencies Preparedness, WHO Headquarters (HQ). Diagnostic Testing for SARS-CoV-2. Interim Guidance 2020. Geneva: World Health Organization (WHO) (2020).</Citation></Reference><Reference><Citation>Garcia-Perez J, Sanchez-Palomino S, Perez-Olmeda M, Fernandez B, Alcami J. A New Strategy Based on Recombinant Viruses as a Tool for Assessing Drug Susceptibility of Human Immunodeficiency Virus Type 1. J Med Virol (2007) 79:127&#x2013;37. doi:&#xa0;10.1002/jmv.20770</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20770</ArticleId><ArticleId IdType="pubmed">17177310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. . Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and its Immune Cross-Reactivity With SARS-CoV. Nat Commun (2020) 11:1620. doi:&#xa0;10.1038/s41467-020-15562-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15562-9</ArticleId><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Fuertes F, Iglesias-Caballero M, Garc&#xed;a-P&#xe9;rez J, Monz&#xf3;n S, Jim&#xe9;nez P, Varona S, et al. . A Founder Effect Led Early SARS-CoV-2 Transmission in Spain. J Virol (2021) 95(3):e01583&#x2013;20. doi:&#xa0;10.1128/JVI.01583-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01583-20</ArticleId><ArticleId IdType="pmc">PMC7925114</ArticleId><ArticleId IdType="pubmed">33127745</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random Forests. Mach Learn (2001) 45:5&#x2013;32. doi:&#xa0;10.1023/A:1010933404324</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010933404324</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer HV, Birney E. PhenotypeSimulator: A Comprehensive Framework for Simulating Multi-Trait, Multi-Locus Genotype to Phenotype Relationships. Bioinformatics (2018) 34:2951&#x2013;6. doi:&#xa0;10.1093/bioinformatics/bty197</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty197</ArticleId><ArticleId IdType="pmc">PMC6129313</ArticleId><ArticleId IdType="pubmed">29617944</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarica A, Cerasa A, Quattrone A. Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer&#x2019;s Disease: A Systematic Review. Front Aging Neurosci (2017) 9:329. doi:&#xa0;10.3389/fnagi.2017.00329</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00329</ArticleId><ArticleId IdType="pmc">PMC5635046</ArticleId><ArticleId IdType="pubmed">29056906</ArticleId></ArticleIdList></Reference><Reference><Citation>Nembrini S, K&#xf6;nig IR, Wright MN. The Revival of the Gini Importance? Bioinformatics (2018) 34:3711&#x2013;8. doi:&#xa0;10.1093/bioinformatics/bty373</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty373</ArticleId><ArticleId IdType="pmc">PMC6198850</ArticleId><ArticleId IdType="pubmed">29757357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female Gender is Associated With Long COVID Syndrome: A Prospective Cohort Study. Clin Microbiol Infect (2021) S1198:00629&#x2013;7. doi:&#xa0;10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. The Coronavirus is Most Deadly If You are Older and Male &#x2014; New Data Reveal the Risks. Nature (2020) 585:16&#x2013;7. doi:&#xa0;10.1038/d41586-020-02483-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02483-2</ArticleId><ArticleId IdType="pubmed">32860026</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, Co-Occurrence, and Evolution of Long-COVID Features: A 6-Month Retrospective Cohort Study of 273,618 Survivors of COVID-19. PloS Med (2021) 18:e1003773. doi:&#xa0;10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Campillo FL, Gallardo LE, Senra A. ABO and Rh Blood Groups in Spain. Rev Sanid Hig Publica (Madr) (1971) 45:1057&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">5004656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness. Ann Intern Med (2021) 174:308&#x2013;15. doi:&#xa0;10.7326/M20-4511</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4511</ArticleId><ArticleId IdType="pmc">PMC7711653</ArticleId><ArticleId IdType="pubmed">33226859</ArticleId></ArticleIdList></Reference><Reference><Citation>Zietz M, Zucker J, Tatonetti NP. Associations Between Blood Type and COVID-19 Infection, Intubation, and Death. Nat Commun (2020) 11:5761. doi:&#xa0;10.1038/s41467-020-19623-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19623-x</ArticleId><ArticleId IdType="pmc">PMC7666188</ArticleId><ArticleId IdType="pubmed">33188185</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaf RK, Al-Samkari H, Brenner SK, Gupta S, Leaf DE. ABO Phenotype and Death in Critically Ill Patients With COVID-19. Br J Haematol (2020) 190:e204&#x2013;8. doi:&#xa0;10.1111/bjh.16984</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16984</ArticleId><ArticleId IdType="pmc">PMC7361419</ArticleId><ArticleId IdType="pubmed">32609874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Latz CA, DeCarlo CS, Lee S, Png CYM, Kibrik P, et al. . Relationship Between Blood Type and Outcomes Following COVID-19 Infection. Semin Vasc Surg (2021) 34:125&#x2013;31. doi:&#xa0;10.1053/j.semvascsurg.2021.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semvascsurg.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8286549</ArticleId><ArticleId IdType="pubmed">34642032</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol (2021) 12:698169:698169. doi:&#xa0;10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Xiao Y, Shen Y, Shi C, Chen Y, Shi P, et al. . Detection of SARS-CoV-2 by RT-PCR in Anal From Patients Who Have Recovered From Coronavirus Disease 2019. J Med Virol (2020) 92:1769&#x2013;71. doi:&#xa0;10.1002/jmv.25875</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25875</ArticleId><ArticleId IdType="pmc">PMC7262280</ArticleId><ArticleId IdType="pubmed">32285947</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Hu W, Yu H, Zhao L, Zhao Y, Zhao X, et al. . Little to No Expression of Angiotensin-Converting Enzyme-2 on Most Human Peripheral Blood Immune Cells But Highly Expressed on Tissue Macrophages. Cytom Part A (2020):cyto.a.24285. doi:&#xa0;10.1002/cyto.a.24285</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.24285</ArticleId><ArticleId IdType="pubmed">33280254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. . SARS-CoV-2 Productively Infects Human Gut Enterocytes. Science (2020) 369:50&#x2013;4. doi:&#xa0;10.1126/science.abc1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf F, Fahriani M, Mamada SS, Frediansyah A, Abubakar A, Maghfirah D, et al. . Global Prevalence of Prolonged Gastrointestinal Symptoms in COVID-19 Survivors and Potential Pathogenesis: A Systematic Review and Meta-Analysis. F1000Research (2021) 10:301. doi:&#xa0;10.12688/f1000research.52216.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52216.1</ArticleId><ArticleId IdType="pmc">PMC8171196</ArticleId><ArticleId IdType="pubmed">34131481</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, et al. . Gut Microbiota Dynamics in a Prospective Cohort of Patients With Post-Acute COVID-19 Syndrome. Gut (2022) 71:544&#x2013;52. doi:&#xa0;10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory Transmucosal SARS-CoV-2 Invasion as a Port of Central Nervous System Entry in Individuals With COVID-19. Nat Neurosci (2021) 24:168&#x2013;75. doi:&#xa0;10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J Pathol (2004) 203:631&#x2013;7. doi:&#xa0;10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2. Front Med (2020) 7:594495:594495. doi:&#xa0;10.3389/fmed.2020.594495</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.594495</ArticleId><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, Signs and Symptoms, and Criteria Adopted for Long COVID-19: A Systematic Review. Int J Clin Pract (2021) 75:e14357. doi:&#xa0;10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann M, Allers K, Heldt C, Meinhardt J, Schmidt F, Rodriguez-Sillke Y, et al. . Human Small Intestinal Infection by SARS-CoV-2 is Characterized by a Mucosal Infiltration With Activated CD8+ T Cells. Mucosal Immunol (2021) 14:1381&#x2013;92. doi:&#xa0;10.1038/s41385-021-00437-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00437-z</ArticleId><ArticleId IdType="pmc">PMC8379580</ArticleId><ArticleId IdType="pubmed">34420043</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An Overview. Diabetes Metab Syndr Clin Res Rev (2021) 15:869&#x2013;75. doi:&#xa0;10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, et al. . Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis (2020) 221:1762&#x2013;9. doi:&#xa0;10.1093/infdis/jiaa150</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa150</ArticleId><ArticleId IdType="pmc">PMC7184346</ArticleId><ArticleId IdType="pubmed">32227123</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquemont L, Tilly G, Yap M, Doan-Ngoc T-M, Danger R, Gu&#xe9;rif P, et al. . Terminally Differentiated Effector Memory CD8 + T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. J Am Soc Nephrol (2020) 31:876&#x2013;91. doi:&#xa0;10.1681/ASN.2019080847</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2019080847</ArticleId><ArticleId IdType="pmc">PMC7191929</ArticleId><ArticleId IdType="pubmed">32165419</ArticleId></ArticleIdList></Reference><Reference><Citation>Raverdeau M, Cunningham SP, Harmon C, Lynch L. &#x3b3;&#x3b4; T Cells in Cancer: A Small Population of Lymphocytes With Big Implications. Clin Transl Immunol (2019) 8:e01080. doi:&#xa0;10.1002/cti2.1080</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1080</ArticleId><ArticleId IdType="pmc">PMC6787154</ArticleId><ArticleId IdType="pubmed">31624593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbaghi A, Miri SM, Keshavarz M, Mahooti M, Zebardast A, Ghaemi A. Role of &#x3b3;&#x3b4; T Cells in Controlling Viral Infections With a Focus on Influenza Virus: Implications for Designing Novel Therapeutic Approaches. Virol J (2020) 17:174. doi:&#xa0;10.1186/s12985-020-01449-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01449-0</ArticleId><ArticleId IdType="pmc">PMC7659406</ArticleId><ArticleId IdType="pubmed">33183352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nrich G, Raftery MJ. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance. Front Cell Infect Microbiol (2019) 9:207. doi:&#xa0;10.3389/fcimb.2019.00207</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00207</ArticleId><ArticleId IdType="pmc">PMC6584848</ArticleId><ArticleId IdType="pubmed">31263684</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmi C, Gao B, Gershwin ME. The Long and Latent Road to Autoimmunity. Cell Mol Immunol (2018) 15:543&#x2013;6. doi:&#xa0;10.1038/s41423-018-0018-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-018-0018-y</ArticleId><ArticleId IdType="pmc">PMC6078962</ArticleId><ArticleId IdType="pubmed">29568115</ArticleId></ArticleIdList></Reference><Reference><Citation>King A. How Pandemics Strengthen Links Between Viruses and Autoimmunity. Nature (2021) 595:S48&#x2013;50. doi:&#xa0;10.1038/d41586-021-01835-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01835-w</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>